ROFL this is not a 505b2! That is unsubstantiated rubbishs.
Explain me why this is 505b2? This is NCE not 505b2. it would be a miracle from god The drug to be on market next year.
Jackie say exciting milestones for GNE MSD but is IMO another mousse study. nothing wrong with a mousse study but only exciting if it leads to license anything else irrelevant. When SPL signs a DEP license then the SP will rise but it’s been about 7 years since SPL did AZ license so I not hold my breath.
i long term holder and I sure not come to same as you conclusion.
Latest quarterly update on AZD0466 today, page-11
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.90M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $37.78K | 385.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 23802 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 39556 | 3 |
View Market Depth
| Last trade - 15.04pm 03/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |